DK1372621T3 - Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor - Google Patents

Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor

Info

Publication number
DK1372621T3
DK1372621T3 DK02720710T DK02720710T DK1372621T3 DK 1372621 T3 DK1372621 T3 DK 1372621T3 DK 02720710 T DK02720710 T DK 02720710T DK 02720710 T DK02720710 T DK 02720710T DK 1372621 T3 DK1372621 T3 DK 1372621T3
Authority
DK
Denmark
Prior art keywords
tyrosine kinase
inhibitor
frk
relates
type
Prior art date
Application number
DK02720710T
Other languages
English (en)
Inventor
Michael Welsh
Cecilia Anneren
Original Assignee
Innoventus Project Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innoventus Project Ab filed Critical Innoventus Project Ab
Application granted granted Critical
Publication of DK1372621T3 publication Critical patent/DK1372621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02720710T 2001-04-06 2002-04-05 Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor DK1372621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101230A SE0101230L (sv) 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor
PCT/SE2002/000682 WO2002080894A1 (en) 2001-04-06 2002-04-05 Novel use of tyrosine kinase inhibitor

Publications (1)

Publication Number Publication Date
DK1372621T3 true DK1372621T3 (da) 2008-10-20

Family

ID=20283697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02720710T DK1372621T3 (da) 2001-04-06 2002-04-05 Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor

Country Status (7)

Country Link
US (1) US20040171563A1 (da)
EP (1) EP1372621B1 (da)
AT (1) ATE397921T1 (da)
DE (1) DE60227058D1 (da)
DK (1) DK1372621T3 (da)
SE (1) SE0101230L (da)
WO (1) WO2002080894A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094682A1 (en) * 2004-10-29 2006-05-04 Odyssey Thera, Inc. Kinase inhibitors for the treatment of diabetes and obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
EP1436259A1 (en) * 2001-09-10 2004-07-14 Congxin Liang 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors

Also Published As

Publication number Publication date
US20040171563A1 (en) 2004-09-02
EP1372621A1 (en) 2004-01-02
EP1372621B1 (en) 2008-06-11
SE0101230L (sv) 2002-10-07
SE0101230D0 (sv) 2001-04-06
ATE397921T1 (de) 2008-07-15
WO2002080894A1 (en) 2002-10-17
DE60227058D1 (da) 2008-07-24

Similar Documents

Publication Publication Date Title
NO20083026L (no) Terapeutisk middel for diabetes
HUP0402403A2 (hu) Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UA88257C2 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ
ATE534404T1 (de) Dipeptidylpeptidase-iv-inhibitoren zur behandlung von diabetes-patienten mit sekundärversagen durch sulfonylharnstoffe
YU34404A (sh) N-supstituisani derivati pirolidina kao inhibitori dipeptidil-peptidaze iv
IS7753A (is) Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki
EA200801538A1 (ru) Лечение диабета 2 типа комбинацией ингибитора дипептидилпептидазы iv (dpiv) и метформина или тиазолидиндиона
MY127961A (en) Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
EA201300550A1 (ru) Фармацевтическая композиция, способы лечения и их применение
EA200900896A1 (ru) Соединения-агонисты гетероциклических рецепторов (варианты), фармацевтическая композиция на их основе, способ лечения диабета и метаболических расстройств, способ стимулирования выработки инсулина (варианты) и способы снижения уровня глюкозы и триглицеридов в крови посредством указанных соединений
DK1224172T3 (da) Medikamenter til behandling af ondartede tumorer
NO20063351L (no) Heteroarylureaer og deres anvendelse som glukokinase aktivatorer
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
DK1523325T3 (da) Fremgangsmåder og sammensætninger til behandling af polycystisk ovariesyndrom
MXPA03011083A (es) Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
AU2003282234A1 (en) Benzofuran derivates, process for their preparation and intermediates thereof
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
WO2006073610A8 (en) Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
DE60110054D1 (en) Cardioprotektive phosphonate
EA200702567A1 (ru) Ингибиторы дипептидил пептидазы iv, основанные на пирролопиридине
RS20060015A (en) Substituted thiazole- benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
WO2006012395A3 (en) Peptidase inhibitors
ATE547396T1 (de) Dicycloalkylcarbamoyl-harnstoffe als glucokinase- aktivatoren